Is TREIF or MRK a better dividend investment in 2026?

TREIF currently yields 412.32% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: TREIF offers higher current income.

What is the dividend yield difference between TREIF and MRK?

TREIF has a forward dividend yield of 412.32% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 409.07 percentage points.

Home › Compare › TREIF vs MRK

TREIF vs MRK: Dividend Comparison 2026

TREIF yields 412.32% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TREIF wins by $14294.98M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TREIF

● Live price

412.32%

Share price

$0.49

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$14295.02M

Annual income

$9,677,801,569.61

Full TREIF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — TREIF vs MRK

📍 TREIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TREIF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TREIF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TREIF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TREIF

Annual income on $10K today (after 15% tax)

$35,047.21/yr

After 10yr DRIP, annual income (after tax)

$8,226,131,334.17/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, TREIF beats the other by $8,226,130,526.42/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TREIF + MRK for your $10,000?

TREIF: 50%MRK: 50%

100% MRK50/50100% TREIF

Portfolio after 10yr

$7147.52M

Annual income

$4,838,901,259.96/yr

Blended yield

67.70%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TREIF

No analyst data

Altman Z

-2.0

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TREIF buys

MRK buys

No recent congressional trades found for TREIF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTREIFMRK

Forward yield	412.32% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$14295.02M ✓	$30.7K
Annual income after 10y	$9,677,801,569.61 ✓	$950.29
Total dividends collected	$13873.65M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: TREIF vs MRK ($10,000, DRIP)

Year	TREIF Portfolio	TREIF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$51,932	$41,232.01	$11,192	$351.54	+$40.7K → TREIF
2	$255,685	$200,117.89	$12,524	$392.70	+$243.2K → TREIF
3	$1,194,398	$920,815.17	$14,015	$438.65	+$1.18M → TREIF
4	$5,298,065	$4,020,058.45	$15,682	$489.96	+$5.28M → TREIF
5	$22,334,365	$16,665,435.68	$17,547	$547.23	+$22.32M → TREIF
6	$89,556,012	$65,658,241.99	$19,632	$611.16	+$89.54M → TREIF
7	$341,876,772	$246,051,838.56	$21,963	$682.53	+$341.85M → TREIF
8	$1,243,652,830	$877,844,684.63	$24,571	$762.18	+$1243.63M → TREIF
9	$4,315,152,804	$2,984,444,275.80	$27,486	$851.08	+$4315.13M → TREIF
10	$14,295,015,070	$9,677,801,569.61	$30,745	$950.29	+$14294.98M → TREIF

TREIF vs MRK: Complete Analysis 2026

TREIF — Stock

Rocket Doctor AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Rocket Doctor AI has built a comprehensive, personalized health care AI engine, the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all health care professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps health care professionals (doctors, nurses or pharmacists) reduce their administrative burden; ...More

Full TREIF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this TREIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TREIF vs SCHD TREIF vs JEPI TREIF vs O TREIF vs KO TREIF vs MAIN TREIF vs JNJ TREIF vs ABBV TREIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.